What is Protagonist Therapeutics's AOCI?

Protagonist Therapeutics (PTGX) reported AOCI of -$269K in Q1 2026.

How has Protagonist Therapeutics's AOCI changed year-over-year?

Protagonist Therapeutics's AOCI decreased by 416.5% year-over-year, from $85K to -$269K.

What is the long-term trend for Protagonist Therapeutics's AOCI?

Over 5 years (2020 to 2025), Protagonist Therapeutics's AOCI has grown at a 87.0% compound annual growth rate (CAGR), from $28K to $641K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Protagonist Therapeutics PTGX AOCI

AOCI at other companies

Bristol-Myers SquibbBMY

-$1.37B+3.8%

Eli LillyLLY

-$2.83B+24.9%

AmgenAMGN

-$190M+17.7%

IncyteINCY

$22.31M+458%

AbbVieABBV

-$1.15B+33.8%

Apogee Therapeutics, Inc.APGE

——

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

FCF margin-12,264.3%-12,527pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's AOCI?: Protagonist Therapeutics (PTGX) reported AOCI of -$269K in Q1 2026.
How has Protagonist Therapeutics's AOCI changed year-over-year?: Protagonist Therapeutics's AOCI decreased by 416.5% year-over-year, from $85K to -$269K.
What is the long-term trend for Protagonist Therapeutics's AOCI?: Over 5 years (2020 to 2025), Protagonist Therapeutics's AOCI has grown at a 87.0% compound annual growth rate (CAGR), from $28K to $641K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.